Study summary

Catheter repair of a leaky tricuspid valve halved death or hospital stays

TRIC-I-HF trial (tricuspid valve repair) · 360 people, randomized trial · Published August 2026, New England Journal of Medicine

52.4%free of death or heart failure hospitalization at 3 years, vs 21.0%

What was tested

Transcatheter tricuspid valve repair plus medicines against medicines alone in symptomatic severe tricuspid regurgitation.

What they found

What it means

Supports earlier valve repair for people with a severely leaking tricuspid valve.

N Engl J Med, via PubMed ↗ Trial record NCT04634266 ↗ ← Back to the outlook
Last reviewed 2026-11-16 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.